Cancer Biopsy Market Size, Share & Trends Analysis Report By Product (Instruments, Kits And Consumables, Services), By Type (Tissue Biopsies, Liquid), By Application, By Region, And Segment Forecasts, 2025

The global cancer biopsy market size was estimated at USD 32.32 billion in 2024 and is projected to reach USD 65.68 billion by 2033, growing at a CAGR of 8.3% from 2025 to 2033. The market growth is attributed to the increasing prevalence of cancer, which is propelling the need for innovative diagnostics to provide early and effective diagnostic solutions to patients.

Moreover, the rising awareness of inherited oncology disorders and the rise in genetic testing are further anticipated to drive the growth of the cancer biopsy industry. The National Cancer Institute (NCI) 2022 update highlights that in the U.S. alone, there were approximately 20 million new cases, resulting in deaths of almost 9.7 million cancer-related deaths worldwide. These substantial figures highlight the growing cancer burden and present a significant growth opportunity for the market.

Due to the advantages of liquid biopsy technologies, massive parallel or NGS has emerged as a rapidly growing and evolving technology with increasing applications in various human Products. An increase in alterations of molecules in various types supports the usage of NGS in clinical settings, as it provides a cost- and time-effective way of detecting cancer. Tumor heterogeneity (evaluating different genes at the same time), along with the need for gene profiling, has increased the use of liquid biopsy, which is expected to propel market growth. Moreover, for various applications, such as prostate, breast, non-small-cell lung, colorectal, and ovarian cancer, liquid biopsy is used for diagnostic & screening, making it an important tool.

The increasing incidence of disease is propelling the demand for the diagnosis of cancers at early stages. For instance, as per Global Cancer Statistics 2024, reported by the American Cancer Society, approximately 20 million cancer cases were newly diagnosed in 2022, and 9.7 million people died from it globally. Moreover, the number of cancer cases is predicted to reach 35 million by 2050. When cancer is discovered early and is contained to the organ of origin before it has a chance to spread, survival rates drastically increase, and it is more likely to be effectively cured. Early detection is crucial for lowering cancer-related mortality, especially through efficient screening programs. Early detection increases patient survival rates by 5 to 10 times more than late detection. The 5-year cancer-specific survival rate is only 21% when cancer is discovered after it has spread, as opposed to 89% when it is found early & still localized.

Furthermore, the increasing number of initiatives by various organizations to raise awareness is a major reason for the growing demand for diagnostic products worldwide. Collaborations and partnerships undertaken by CDC, WHO, the National Cervical Cancer Coalition, the U.S. Preventive Services Task Force, & others are expected to drive market growth by increasing cervical cancer screening rates. In addition, major market players are undertaking initiatives to increase awareness about cervical, vulvar, and vaginal cancer, which is likely to encourage people to opt for screening at regular intervals.

For instance, in 2024, India, the U.S., Australia, and Japan launched the Quad Cancer Moonshot Initiative, which was specifically focused on eliminating cervical cancer across the Indo-Pacific region. Similarly, in October 2024, the University of New South Wales (UNSW) Sydney received a donation of USD 25.9 million from the Swire Group. This funding allowed the Kirby Institute at UNSW Sydney to screen 130,000 women in seven Pacific countries, including Fiji, Kiribati, the Republic of Marshall Islands, Samoa, Solomon Islands, Tonga, and Vanuatu, for cervical cancer.

Moreover, awareness among people about early diagnosis and available treatment options and advancements in treatments has substantially improved patient outcomes. According to a Cancer Progress Report published by the American Association for Cancer Research, it was expected that in the U.S., around 2,001,140 new cases of cancer would be diagnosed in 2024, and approximately 611,720 people might die from the Disease.

However, the high cost of diagnostic tests is anticipated to hamper the overall market growth. Diagnostic cancer tests are expensive, increasing the financial burden on families of patients. The government insurance framework is less well-defined in developing countries than in developed countries. Thus, the middle-class patient population who are uninsured cannot afford these tests. In addition, many private insurance players do not cover costs associated with diagnosis in developing countries. As a result, the high cost of diagnosis is limiting the adoption of screening tools, especially in developing countries. However, the scenario is expected to change in the coming years due to booming medical tourism in countries such as India and Malaysia, wherein healthcare treatments & diagnostic solutions are becoming affordable.

Global Cancer Biopsy Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cancer biopsy market report based on product, type, application, and region:

Product Outlook (Revenue, USD Million, 2021 - 2033)
Instruments
Kits & Consumables
Services
Type Outlook (Revenue, USD Million, 2021 - 2033)
Tissue Biopsies
- Needle Biopsies
- Surgical Biopsies
Liquid Biopsies
- Fine Needle Aspiration (FNA)
- Core Needle Biopsy (CNB)
Others
Application Outlook (Revenue, USD Million, 2021 - 2033)
Breast Cancer
Colorectal Cancer
Cervical Cancers
Lung Cancers
Prostate Cancers
Skin Cancers
Blood Cancers
Kidney Cancers
Liver Cancers
Pancreatic Cancers
Ovarian Cancers
Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Product Code: GVR-4-68039-254-2

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Type
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information Analysis
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
- 1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Cancer Biopsy Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1. Supplier Power
  - 3.3.1.2. Buyer Power
  - 3.3.1.3. Substitution Threat
  - 3.3.1.4. Threat of New Entrants
  - 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis

Chapter 4. Cancer Biopsy Market: Product Business Analysis

4.1. Product Market Share, 2024 & 2033
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Instruments
- 4.4.1. Instruments Market, 2021 - 2033 (USD Million)
4.5. Kits and Consumables
- 4.5.1. Kits and Consumables Market, 2021 - 2033 (USD Million)
4.6. Services
- 4.6.1. Services Market, 2021 - 2033 (USD Million)

Chapter 5. Cancer Biopsy Market: Type Business Analysis

5.1. Type Market Share, 2024 & 2033
5.2. Type Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Type, 2021 to 2033 (USD Million)
5.4. Tissue Biopsies
- 5.4.1. Tissue Biopsies Market, 2021 - 2033 (USD Million)
  - 5.4.1.1. Needle Biopsies
    - 5.4.1.1.1. Needle Biopsies Market, 2021 - 2033 (USD Million)
  - 5.4.1.2. Surgical Biopsies
    - 5.4.1.2.1. Surgical Biopsies Market, 2021 - 2033 (USD Million)
5.5. Liquid Biopsies
- 5.5.1. Liquid Biopsies Market, 2021 - 2033 (USD Million)
  - 5.5.1.1. Fine Needle Aspiration (FNA)
    - 5.5.1.1.1. Fine Needle Aspiration (FNA) Market, 2021 - 2033 (USD Million)
  - 5.5.1.2. Core Needle Biopsy (CNB)
    - 5.5.1.2.1. Core Needle Biopsy (CNB) Market, 2021 - 2033 (USD Million)
5.6. Others

Chapter 6. Cancer Biopsy Market: Application Business Analysis

6.1. Application Market Share, 2024 & 2033
6.2. Application Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Type, 2021 to 2033 (USD Million)
6.4. Breast Cancer
- 6.4.1. Breast Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Colorectal Cancer
- 6.5.1. Colorectal Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Cervical Cancers
- 6.6.1. Cervical Cancers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Lung Cancers
- 6.7.1. Lung Cancers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Prostate Cancers
- 6.8.1. Prostate Cancers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.9. Skin Cancers
- 6.9.1. Skin Cancers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.10. Blood Cancers
- 6.10.1. Blood Cancers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.11. Kidney Cancers
- 6.11.1. Kidney Cancers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.12. Liver Cancers
- 6.12.1. Liver Cancers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.13. Pancreatic Cancers
- 6.13.1. Pancreatic Cancers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.14. Ovarian Cancers
- 6.14.1. Ovarian Cancers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.15. Others
- 6.15.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Cancer Biopsy Market: Regional Estimates & Trend Analysis

7.1. Regional Market Share Analysis, 2024 & 2033
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
7.4. North America
- 7.4.1. North America Cancer Biopsy Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
- 7.4.2. U.S.
  - 7.4.2.1. Key Country Dynamics
  - 7.4.2.2. U.S. Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.3. Canada
  - 7.4.3.1. Key Country Dynamics
  - 7.4.3.2. Canada Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.4. Mexico
  - 7.4.4.1. Key Country Dynamics
  - 7.4.4.2. Mexico Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Europe
- 7.5.1. Europe Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.2. UK
  - 7.5.2.1. Key Country Dynamics
  - 7.5.2.2. UK Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.3. Germany
  - 7.5.3.1. Key Country Dynamics
  - 7.5.3.2. Germany Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.4. France
  - 7.5.4.1. Key Country Dynamics
  - 7.5.4.2. France Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.5. Italy
  - 7.5.5.1. Key Country Dynamics
  - 7.5.5.2. Italy Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.6. Spain
  - 7.5.6.1. Key Country Dynamics
  - 7.5.6.2. Spain Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.7. Denmark
  - 7.5.7.1. Key Country Dynamics
  - 7.5.7.2. Denmark Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.8. Sweden
  - 7.5.8.1. Key Country Dynamics
  - 7.5.8.2. Sweden Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.9. Norway
  - 7.5.9.1. Key Country Dynamics
  - 7.5.9.2. Norway Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Asia Pacific
- 7.6.1. Asia Pacific Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.2. Japan
  - 7.6.2.1. Key Country Dynamics
  - 7.6.2.2. Japan Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.3. China
  - 7.6.3.1. Key Country Dynamics
  - 7.6.3.2. China Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.4. India
  - 7.6.4.1. Key Country Dynamics
  - 7.6.4.2. India Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.5. Australia
  - 7.6.5.1. Key Country Dynamics
  - 7.6.5.2. Australia Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.6. South Korea
  - 7.6.6.1. Key Country Dynamics
  - 7.6.6.2. South Korea Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.7. Thailand
  - 7.6.7.1. Key Country Dynamics
  - 7.6.7.2. Thailand Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Latin America
- 7.7.1. Latin America Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.2. Brazil
  - 7.7.2.1. Key Country Dynamics
  - 7.7.2.2. Japan Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.3. Argentina
  - 7.7.3.1. Key Country Dynamics
  - 7.7.3.2. China Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8. Middle East and Africa
- 7.8.1. Middle East and Africa Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.2. South Africa
  - 7.8.2.1. Key Country Dynamics
  - 7.8.2.2. South Africa Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.3. Saudi Arabia
  - 7.8.3.1. Key Country Dynamics
  - 7.8.3.2. Saudi Arabia Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.4. UAE
  - 7.8.4.1. Key Country Dynamics
  - 7.8.4.2. UAE Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.5. Kuwait
  - 7.8.5.1. Key Country Dynamics
  - 7.8.5.2. Kuwait Cancer Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
- 8.5.1. QIAGEN
  - 8.5.1.1. Overview
  - 8.5.1.2. Financial Performance
  - 8.5.1.3. Product Benchmarking
  - 8.5.1.4. Strategic Initiatives
- 8.5.2. Illumina, Inc.
  - 8.5.2.1. Overview
  - 8.5.2.2. Financial Performance
  - 8.5.2.3. Product Benchmarking
  - 8.5.2.4. Strategic Initiatives
- 8.5.3. ANGLE plc
  - 8.5.3.1. Overview
  - 8.5.3.2. Financial Performance
  - 8.5.3.3. Product Benchmarking
  - 8.5.3.4. Strategic Initiatives
- 8.5.4. BD (Becton, Dickinson and Company)
  - 8.5.4.1. Overview
  - 8.5.4.2. Financial Performance
  - 8.5.4.3. Product Benchmarking
  - 8.5.4.4. Strategic Initiatives
- 8.5.5. Myriad Genetics, Inc.
  - 8.5.5.1. Overview
  - 8.5.5.2. Financial Performance
  - 8.5.5.3. Product Benchmarking
  - 8.5.5.4. Strategic Initiatives
- 8.5.6. Hologic, Inc.
  - 8.5.6.1. Overview
  - 8.5.6.2. Financial Performance
  - 8.5.6.3. Product Benchmarking
  - 8.5.6.4. Strategic Initiatives
- 8.5.7. Biocept, Inc.
  - 8.5.7.1. Overview
  - 8.5.7.2. Financial Performance
  - 8.5.7.3. Product Benchmarking
  - 8.5.7.4. Strategic Initiatives
- 8.5.8. Thermo Fisher Scientific, Inc.
  - 8.5.8.1. Overview
  - 8.5.8.2. Financial Performance
  - 8.5.8.3. Product Benchmarking
  - 8.5.8.4. Strategic Initiatives
- 8.5.9. Danaher
  - 8.5.9.1. Overview
  - 8.5.9.2. Financial Performance
  - 8.5.9.3. Product Benchmarking
  - 8.5.9.4. Strategic Initiatives
- 8.5.10. F. Hoffmann-La Roche Ltd.
  - 8.5.10.1. Overview
  - 8.5.10.2. Financial Performance
  - 8.5.10.3. Product Benchmarking
  - 8.5.10.4. Strategic Initiatives
- 8.5.11. Lucence Health Inc.
  - 8.5.11.1. Overview
  - 8.5.11.2. Financial Performance
  - 8.5.11.3. Product Benchmarking
  - 8.5.11.4. Strategic Initiatives
- 8.5.12. GRAIL, Inc.
  - 8.5.12.1. Overview
  - 8.5.12.2. Financial Performance
  - 8.5.12.3. Product Benchmarking
  - 8.5.12.4. Strategic Initiatives
- 8.5.13. Guardant Health Inc.
  - 8.5.13.1. Overview
  - 8.5.13.2. Financial Performance
  - 8.5.13.3. Product Benchmarking
  - 8.5.13.4. Strategic Initiatives
- 8.5.14. Exact Sciences Corporation
  - 8.5.14.1. Overview
  - 8.5.14.2. Financial Performance
  - 8.5.14.3. Product Benchmarking
  - 8.5.14.4. Strategic Initiatives
- 8.5.15. Freenome Holdings, Inc.
  - 8.5.15.1. Overview
  - 8.5.15.2. Financial Performance
  - 8.5.15.3. Product Benchmarking
  - 8.5.15.4. Strategic Initiatives
- 8.5.16. Biodesix (Integrated Diagnostics)
  - 8.5.16.1. Overview
  - 8.5.16.2. Financial Performance
  - 8.5.16.3. Product Benchmarking
  - 8.5.16.4. Strategic Initiatives
- 8.5.17. Oncimmune
  - 8.5.17.1. Overview
  - 8.5.17.2. Financial Performance
  - 8.5.17.3. Product Benchmarking
  - 8.5.17.4. Strategic Initiatives
- 8.5.18. Epigenomics AG
  - 8.5.18.1. Overview
  - 8.5.18.2. Financial Performance
  - 8.5.18.3. Product Benchmarking
  - 8.5.18.4. Strategic Initiatives
- 8.5.19. HelioHealth (Laboratory for Advanced Medicine)
  - 8.5.19.1. Overview
  - 8.5.19.2. Financial Performance
  - 8.5.19.3. Product Benchmarking
  - 8.5.19.4. Strategic Initiatives
- 8.5.20. Genesystems, Inc. (Genesys Biolabs)
  - 8.5.20.1. Overview
  - 8.5.20.2. Financial Performance
  - 8.5.20.3. Product Benchmarking
  - 8.5.20.4. Strategic Initiatives
- 8.5.21. Chronix Biomedical, Inc.
  - 8.5.21.1. Overview
  - 8.5.21.2. Financial Performance
  - 8.5.21.3. Product Benchmarking
  - 8.5.21.4. Strategic Initiatives
- 8.5.22. Personal Genome Diagnostics Inc.
  - 8.5.22.1. Overview
  - 8.5.22.2. Financial Performance
  - 8.5.22.3. Product Benchmarking
  - 8.5.22.4. Strategic Initiatives
- 8.5.23. Natera, Inc.
  - 8.5.23.1. Overview
  - 8.5.23.2. Financial Performance
  - 8.5.23.3. Product Benchmarking
  - 8.5.23.4. Strategic Initiatives
- 8.5.24. Personalis Inc.
  - 8.5.24.1. Overview
  - 8.5.24.2. Financial Performance
  - 8.5.24.3. Product Benchmarking
  - 8.5.24.4. Strategic Initiatives

Product Code: GVR-4-68039-254-2

List of Tables

Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global Cancer Biopsy Market, by region, 2021 - 2033 (USD Million)
Table 4. Global Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 5. Global Cancer Biopsy Market, by distribution channel, 2021 - 2033 (USD Million)
Table 6. North America Cancer Biopsy Market, by country, 2021 - 2033 (USD Million)
Table 7. North America Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 8. North America Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 9. North America Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 10. U.S. Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 11. U.S. Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 12. U.S. Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 13. Canada Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 14. Canada Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 15. Canada Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 16. Mexico Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 17. Mexico Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 18. Mexico Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 19. Europe Cancer Biopsy Market, by Country, 2021 - 2033 (USD Million)
Table 20. Europe Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 21. Europe Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 22. Europe Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 23. UK Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 24. UK Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 25. UK Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 26. Germany Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 27. Germany Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 28. Germany Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 29. France Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 30. France Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 31. France Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 32. Italy Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 33. Italy Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 34. Italy Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 35. Spain Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 36. Spain Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 37. Spain Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 38. Norway Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 39. Norway Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 40. Norway Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 41. Denmark Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 42. Denmark Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 43. Denmark Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 44. Sweden Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 45. Sweden Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 46. Sweden Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 47. Asia Pacific Cancer Biopsy Market, by Country, 2021 - 2033 (USD Million)
Table 48. Asia Pacific Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 49. Asia Pacific Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 50. Asia Pacific Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 51. Japan Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 52. Japan Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 53. Japan Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 54. China Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 55. China Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 56. China Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 57. India Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 58. India Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 59. India Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 60. Australia Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 61. Australia Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 62. Australia Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 63. South Korea Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 64. South Korea Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 65. South Korea Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 66. Thailand Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 67. Thailand Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 68. Thailand Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 69. Latin America Cancer Biopsy Market, by country, 2021 - 2033 (USD Million)
Table 70. Latin America Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 71. Latin America Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 72. Latin America Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 73. Brazil Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 74. Brazil Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 75. Brazil Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 76. Argentina Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 77. Argentina Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 78. Argentina Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 79. Middle East & Africa Cancer Biopsy Market, by Country, 2021 - 2033 (USD Million)
Table 80. Middle East & Africa Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 81. Middle East & Africa Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 82. Middle East & Africa Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 83. South Africa Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 84. South Africa Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 85. South Africa Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 86. Saudi Arabia Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 87. Saudi Arabia Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 88. Saudi Arabia Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 89. UAE Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 90. UAE Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 91. UAE Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)
Table 92. Kuwait Cancer Biopsy Market, by Product, 2021 - 2033 (USD Million)
Table 93. Kuwait Cancer Biopsy Market, by Type, 2021 - 2033 (USD Million)
Table 94. Kuwait Cancer Biopsy Market, by Application, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Cancer Biopsy Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Therapeutic approach and Product outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Cancer Biopsy Market dynamics
Fig. 12 Cancer Biopsy Market: Porter's five forces analysis
Fig. 13 Cancer Biopsy Market: PESTLE analysis
Fig. 14 Product market, 2021 - 2033 (USD Million)
Fig. 15 Instruments market, 2021 - 2033 (USD Million)
Fig. 16 Kits and Consumables market, 2021 - 2033 (USD Million)
Fig. 17 Services market, 2021 - 2033 (USD Million)
Fig. 18 Type market, 2021 - 2033 (USD Million)
Fig. 19 Tissue Biopsies market, 2021 - 2033 (USD Million)
Fig. 20 Liquid Biopsies market, 2021 - 2033 (USD Million)
Fig. 21 Others market, 2021 - 2033 (USD Million)
Fig. 22 Application market, 2021 - 2033 (USD Million)
Fig. 23 Breast Cancer market, 2021 - 2033 (USD Million)
Fig. 24 Colorectal Cancer market, 2021 - 2033 (USD Million)
Fig. 25 Cervical Cancer market, 2021 - 2033 (USD Million)
Fig. 26 Lung Cancer market, 2021 - 2033 (USD Million)
Fig. 27 Prostate Cancer market, 2021 - 2033 (USD Million)
Fig. 28 Skin Cancer market, 2021 - 2033 (USD Million)
Fig. 29 Blood Cancer market, 2021 - 2033 (USD Million)
Fig. 30 Kidney Cancer market, 2021 - 2033 (USD Million)
Fig. 31 Liver Cancer market, 2021 - 2033 (USD Million)
Fig. 32 Pancreatic Cancer market, 2021 - 2033 (USD Million)
Fig. 33 Ovarian Cancer market, 2021 - 2033 (USD Million)
Fig. 34 Others market, 2021 - 2033 (USD Million)
Fig. 35 Cancer Biopsy Market revenue, by region
Fig. 36 Regional marketplace: Key takeaways
Fig. 37 North America Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 38 U.S. country dynamics
Fig. 39 U.S. Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 40 Canada country dynamics
Fig. 41 Canada Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 42 Mexico country dynamics
Fig. 43 Mexico Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 44 Europe Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 45 UK country dynamics
Fig. 46 UK Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 47 Germany country dynamics
Fig. 48 Germany Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 49 France country dynamics
Fig. 50 France Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 51 Italy country dynamics
Fig. 52 Italy Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 53 Spain country dynamics
Fig. 54 Spain Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 55 Norway country dynamics
Fig. 56 Norway Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 57 Sweden country dynamics
Fig. 58 Sweden Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 59 Denmark country dynamics
Fig. 60 Denmark Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 61 Asia Pacific Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 62 Japan country dynamics
Fig. 63 Japan Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 64 China country dynamics
Fig. 65 China Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 66 India country dynamics
Fig. 67 India Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 68 Australia country dynamics
Fig. 69 Australia Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 70 South Korea country dynamics
Fig. 71 South Korea Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 72 Thailand country dynamics
Fig. 73 Thailand Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 74 Latin America Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 75 Brazil country dynamics
Fig. 76 Brazil Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 77 Argentina country dynamics
Fig. 78 Argentina Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 79 MEA Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 80 South Africa country dynamics
Fig. 81 South Africa Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 82 Saudi Arabia country dynamics
Fig. 83 Saudi Arabia Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 84 UAE country dynamics
Fig. 85 UAE Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 86 Kuwait country dynamics
Fig. 87 Kuwait Cancer Biopsy Market, 2021 - 2033 (USD Million)
Fig. 88 Company categorization
Fig. 89 Company market position analysis
Fig. 90 Strategic framework

Cancer Biopsy Market Size, Share & Trends Analysis Report By Product (Instruments, Kits And Consumables, Services), By Type (Tissue Biopsies, Liquid), By Application, By Region, And Segment Forecasts, 2025 - 2033

Description

Table of Contents

List of Tables

Cancer Biopsy Market Summary

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Cancer Biopsy Market Variables, Trends, & Scope

Chapter 4. Cancer Biopsy Market: Product Business Analysis

Chapter 5. Cancer Biopsy Market: Type Business Analysis

Chapter 6. Cancer Biopsy Market: Application Business Analysis

Chapter 7. Cancer Biopsy Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

List of Tables

List of Figures